Print this page
-
Optimal Perioperative Therapy For Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial.
Protocol: 072306Principal Investigator:
- Brett Ecker MD (Rutgers Cancer Institute of New Jersey-University Hospital)
Applicable Disease Sites: Other Digestive Organ -
A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer.
Protocol: 071807Principal Investigator:
- Howard Hochster M.D (Rutgers University)
Applicable Disease Sites: Colon -
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer.
Protocol: 072108Principal Investigator:
- Russell Langan MD (Cooperman Barnabas, Livingston)
Applicable Disease Sites: Pancreas -
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
Protocol: 001720Principal Investigator:
- Vinod Rustgi MD, MBA (Robert Wood Johnson Medical School)
Applicable Disease Sites: Liver -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah Toppmeyer M.D. (Rutgers University)
Applicable Disease Sites: Pancreas
Melanoma, Skin
Colon
Ovary
Soft Tissue
Prostate
Kidney
Breast -
Personalized Oncology Promoting Equity for Black Lives (PROPEL)
Protocol: 132309Principal Investigator:
- Anita Kinney PhD,RN (Rutgers University)
Applicable Disease Sites: Corpus Uteri
Prostate
Pancreas
Breast
Ovary
Colon